LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-10-25
Case ID: NM_000314.8_c.18A_C_20261025_013855
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.18A>C

PTEN  · NP_000305.3:p.(Lys6Asn)  · NM_000314.8
GRCh37: chr10:89624244 A>C  ·  GRCh38: chr10:87864487 A>C
Gene: PTEN Transcript: NM_000314.8
Final call
VUS
PM2 supporting PP2 supporting BP4 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Lys6Asn)
gnomAD AF
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1.
2
PP2 supporting: p.Lys6Asn is a missense variant covered by the PTEN VCEP PP2 specification.
3
BP4 supporting: the REVEL score is 0.489, below the PTEN VCEP cutoff of 0.5.
Final determination: Under the PTEN VCEP Version 3.2 combining rules, the applied PM2, PP2, and BP4 supporting criteria satisfy neither a pathogenic rule nor a benign rule, so the variant is classified as VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: c.18A>C is a missense substitution, whereas the PTEN PVS1 decision tree covers specified loss-of-function consequence classes.
cspec vcep_pvs1_decisiontree_pten
PS1 Not assessed Not assessed: no verified previously established pathogenic variant with the same p.Lys6Asn amino-acid change was available, and comparator retrieval had a documented soft failure.
cspec clinvar pm5_candidates
PS2 Not assessed Not assessed: no proband-level de novo observation, parental testing, maternity/paternity confirmation, or family-history information is available.
cspec
PS3 Not met Not met: high-confidence K6N Cum_score was -1.045273268, above the PTEN VCEP PS3_Moderate cutoff of <= -1.11.
vcep_mmc2 PMID:29706350 PMID:27147599
PS4 Not assessed Not assessed: no case-control statistics or phenotype-specificity score are available to compare with the VCEP's PS4 requirements.
cspec
PM1 Not met Not met: p.Lys6Asn is at residue 6, outside VCEP catalytic motifs 90-94, 123-130, and 166-168, with no statistically significant hotspot reported.
cspec
PM2 Met Met at Supporting: the variant is absent from gnomAD v2.1 and v4.1, satisfying the PTEN VCEP PM2 threshold of <0.00001 (0.001%).
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP explicitly marks PM3 “Not Applicable.”
cspec
PM4 N/A Not applicable: p.(Lys6Asn) is a missense substitution with no protein-length change, not an in-frame indel or stop-loss variant.
cspec
PM5 Not assessed Not assessed: no qualifying pathogenic or likely pathogenic alternate missense at Lys6 was verified, and the required BLOSUM62 comparison is unavailable.
cspec pm5_candidates
PM6 Not assessed Not assessed: zero documented presumed or assumed de novo observations and no disease or family-history data are available.
cspec
PP1 Not assessed Not assessed: no affected relatives, co-segregation observations, or meiosis count are documented for this variant.
cspec
PP2 Met Met at supporting strength: p.Lys6Asn is a missense variant, and the PTEN VCEP specifies PP2 for PTEN's low benign-missense rate and common missense disease mechanism.
cspec
PP3 Not met Not met: the missense REVEL score is 0.489, below the PTEN VCEP PP3 threshold of greater than 0.7.
cspec revel
PP4 N/A Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 rather than allowing independent PP4 use.
cspec
PP5 N/A Not applicable: the PTEN VCEP explicitly prohibits use of PP5 under its specification.
cspec
BA1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the BA1 threshold of >0.00056 (0.056%).
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: no gnomAD allele frequency was observed, so the variant does not fall within either BS1 interval from 0.0000043 to 0.00056.
cspec gnomad_v2 gnomad_v4
BS2 Not met Not met: gnomAD v2.1 and v4.1 report zero observed alleles, providing no homozygous healthy-individual observation required for BS2.
cspec gnomad_v2 gnomad_v4
BS3 Not met Not met: high-confidence K6N Cum_score was -1.045273268, not greater than the PTEN VCEP BS3_Supporting threshold of >0.
vcep_mmc2 PMID:29706350 PMID:27147599
BS4 Not assessed Not assessed: no affected-family testing or lack-of-segregation observation is documented in one or more families.
cspec
BP1 N/A Not applicable: the PTEN VCEP explicitly marks BP1 as Not Applicable.
cspec
BP2 Not assessed Not assessed: no cis/trans or phase information links this variant to a different pathogenic or likely pathogenic PTEN variant.
cspec clinvar
BP3 N/A Not applicable: the PTEN VCEP explicitly marks BP3 as Not Applicable, and this variant is a missense substitution.
cspec
BP4 Met Met: the missense REVEL score is 0.489, below the PTEN VCEP BP4 threshold of less than 0.5.
cspec revel
BP5 Not assessed Not assessed: no two qualifying cases with a highly penetrant alternate disorder and non-overlapping PTEN history are documented.
cspec
BP6 N/A Not applicable: the PTEN VCEP explicitly prohibits use of BP6 under its specification.
cspec
BP7 N/A Not applicable: c.18A>C is an exonic missense variant, whereas PTEN VCEP BP7 covers only synonymous or intronic variants at or beyond +7/-21.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.